Dr. Gavin Peter Dunn, MD, PhD

Dr. Dunn practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Dunn's NPI, 1760519193, was assigned on February 27, 2007. Dr. Dunn graduated from WashU Medicine in 2006. Dr. Dunn holds Massachusetts license 249192.

Dr. Dunn's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Dunn's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Dunn is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Dunn to 2 more hospitals, 1 community health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dunn practices, 5 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Dunn's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Dunn is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Dunn's licenses on file in 5 states: Massachusetts, Maine, New Hampshire, Missouri and Illinois.

Dmand AI lists craniotomy among the conditions Dr. Dunn treats.

CMS data shows 146 Medicare services from Dr. Dunn across 8 procedure codes in 2024, for 123 Medicare patients. Medicare paid $33,690 for them.

CMS counts 123 Medicare patients who saw Dr. Dunn in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dunn's median patient age at 68, with 43% women.

In 2021, Dr. Dunn wrote 63 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $1,597 in total drug cost. In 2020, CMS named 52 claims across 2 drugs.

Dr. Dunn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dunn as offering telehealth.

Dmand AI links 148 papers to Dr. Dunn, published from 2006 to 2025. 2016 was the busiest year, with 11. The most frequent topics are Brain Neoplasms, Glioblastoma and Immunotherapy. Dr. Dunn has published most often in Clin Cancer Res. Dr. Dunn's most frequent co-authors are Tanner Michael Johanns, MD, Michael R. Chicoine, MD and Eric Claude Leuthardt, MD.

Dmand AI links Dr. Dunn to 11 clinical trials, 5 of them phase 1 studies. 5 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Meningioma. Washington University School of Medicine sponsors the most, 9.

CMS Open Payments shows 7 general payments to Dr. Dunn from 6 drug and device companies from 2017 to 2021. Honoraria make up the largest share, 70% of the total. Brainlab, Inc. paid the most, $2,000.

Dr. Dunn graduated from WashU Medicine in 2006. Dr. Dunn is a member of CNS.

Dr. Dunn is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.